<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://healthcarenews.work/</loc><changefreq>daily</changefreq><priority>1.0</priority></url>
  <url><loc>https://healthcarenews.work/news/</loc><changefreq>daily</changefreq><priority>0.9</priority></url>
  <url><loc>https://healthcarenews.work/about/</loc><changefreq>monthly</changefreq><priority>0.5</priority></url>
  <url><loc>https://healthcarenews.work/submit/</loc><changefreq>monthly</changefreq><priority>0.4</priority></url>
  
  
  <url>
    <loc>https://healthcarenews.work/news/2026-04-13-stryker-signs-definitive-agreement-acquire-amplitude-vascular-systems/</loc>
    <lastmod>2026-04-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-04-13</news:publication_date>
      <news:title>Stryker to Acquire Amplitude Vascular Systems, Adding Lithotripsy Technology to Vascular Portfolio</news:title>
      <news:keywords>Acquisition, Peripheral Vascular, Medical Devices, Corporate Development</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-04-13-medtronic-to-announce-financial-results-for-its-fourth-quarter-and-full-fiscal-year-2026/</loc>
    <lastmod>2026-04-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-04-13</news:publication_date>
      <news:title>Medtronic Sets June 3 Date for Fourth-Quarter and Full Fiscal Year 2026 Results</news:title>
      <news:keywords>Corporate, Financial Results, Earnings Announcement, Investor Relations</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-04-13-dupixent-approved-eu-chronic-spontaneous-urticaria-young-children/</loc>
    <lastmod>2026-04-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-04-13</news:publication_date>
      <news:title>EU Approves Dupixent as First Targeted Treatment for Young Children with Chronic Spontaneous Urticaria</news:title>
      <news:keywords>Regulatory Approval, Immunology, Pediatrics, European Commission</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-04-09-novartis-announces-expansion-community-health-programs-close-gaps-heart-disease-and-cancer-care/</loc>
    <lastmod>2026-04-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-04-09</news:publication_date>
      <news:title>Novartis Expands Community Health Programs to 30-Plus Countries by 2030 to Address Heart Disease and Cancer Gaps</news:title>
      <news:keywords>Social Commitment, Reimagine Medicine, Innovation, Cancer, Heart Disease</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-04-09-new-survey-finds-most-americans-believe-chronic-diseases-are-preventable/</loc>
    <lastmod>2026-04-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-04-09</news:publication_date>
      <news:title>Abbott Survey Reveals Gap Between Americans&apos; Belief in Disease Prevention and Their Health Confidence</news:title>
      <news:keywords>Chronic Disease, Health Survey, Consumer Health, Nutrition, Disease Prevention</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-04-07-lunsekimig-phase2-asthma-crsnwp/</loc>
    <lastmod>2026-04-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-04-07</news:publication_date>
      <news:title>Sanofi&apos;s Bispecific Antibody Lunsekimig Meets Key Endpoints in Asthma and Nasal Polyp Studies</news:title>
      <news:keywords>Clinical Trial Results, Immunology, Respiratory, Phase 2</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-31-rezurock-approved-eu-chronic-graft-vs-host-disease/</loc>
    <lastmod>2026-03-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-31</news:publication_date>
      <news:title>EU Approves Sanofi&apos;s Rezurock for Chronic Graft-Versus-Host Disease</news:title>
      <news:keywords>Regulatory Approval, Oncology, Rare Disease, European Commission</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-30-abbott-expands-access-to-precision-oncology-portfolio-through-integration-with-flatiron-oncoemr/</loc>
    <lastmod>2026-03-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-30</news:publication_date>
      <news:title>Abbott Integrates Precision Oncology Tests Into Flatiron&apos;s OncoEMR Platform</news:title>
      <news:keywords>Precision Oncology, Healthcare Technology, Electronic Medical Records, Cancer Diagnostics, Medical Devices</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-29-novartis-igan-data-new-england-journal-medicine-show-fabhalta-slowed-kidney-function-decline-493/</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-29</news:publication_date>
      <news:title>Novartis&apos;s Fabhalta Slows Kidney Function Decline by Nearly 50% in IgA Nephropathy Trial</news:title>
      <news:keywords>Reimagine Medicine, Rare Diseases, Clinical Trials, Kidney Disease, Nephrology</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-28-amlitelimab-phase3-atopic-dermatitis-aad/</loc>
    <lastmod>2026-03-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-28</news:publication_date>
      <news:title>Sanofi&apos;s Amlitelimab Shows Positive Phase 3 Results in Atopic Dermatitis at AAD Meeting</news:title>
      <news:keywords>Clinical Trial Results, Dermatology, Immunology, Phase 3, Conference Presentation</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-27-sarclisa-subcutaneous-chmp-multiple-myeloma/</loc>
    <lastmod>2026-03-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-27</news:publication_date>
      <news:title>EU Panel Recommends Approval of Sanofi&apos;s Sarclisa Subcutaneous Formulation for Multiple Myeloma</news:title>
      <news:keywords>Regulatory Approval, Oncology, Multiple Myeloma, CHMP</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-27-novartis-agrees-acquire-excellergy-inc-building-allergy-leadership-next-generation-anti-ige-innovation/</loc>
    <lastmod>2026-03-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-27</news:publication_date>
      <news:title>Novartis to Acquire Excellergy for Up to $2 Billion, Adding Next-Generation Anti-IgE Therapy</news:title>
      <news:keywords>Innovation, Reimagine Medicine, Acquisition, Immunology, Allergy</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-27-medtronic-receives-fda-clearance-for-stealth-axis-surgical-system-for-cranial-and-ent-procedures/</loc>
    <lastmod>2026-03-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-27</news:publication_date>
      <news:title>Medtronic Wins FDA Clearance for AI-Enabled Stealth AXiS Surgical System for Brain and ENT Surgery</news:title>
      <news:keywords>Neuroscience Portfolio, Surgical Robotics, Medical Devices, FDA Clearance, Cranial Surgery</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-26-uhc-introduces-ai-companion-empowering-people-with-simpler-navigation-personal-experience/</loc>
    <lastmod>2026-03-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-26</news:publication_date>
      <news:title>UnitedHealthcare Launches AI-Powered Health Navigation Tool for Millions of Members</news:title>
      <news:keywords>Artificial Intelligence, Technology, Member Experience, Healthcare Navigation</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-26-abbott-hosts-conference-call-for-first-quarter-earnings/</loc>
    <lastmod>2026-03-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-26</news:publication_date>
      <news:title>Abbott Schedules First-Quarter 2026 Earnings Release for April 16</news:title>
      <news:keywords>Earnings, Investor Relations, Financial Results, Conference Call</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-24-q1-2026-aide-memoire-availability/</loc>
    <lastmod>2026-03-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-24</news:publication_date>
      <news:title>Sanofi Publishes Q1 2026 Financial Modeling Document Ahead of April Earnings</news:title>
      <news:keywords>Investor Relations, Financial Reporting, Q1 2026</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-24-medtronic-and-merit-medical-systems-enter-into-agreement-to-offer-new-fda-cleared-viaverte-system/</loc>
    <lastmod>2026-03-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-24</news:publication_date>
      <news:title>Medtronic Partners with Merit Medical to Offer New Nerve Ablation System for Chronic Lower-Back Pain</news:title>
      <news:keywords>Neuroscience Portfolio, Medical Devices, Pain Management, Minimally Invasive Procedures, FDA Clearance</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-24-dupixent-approved-japan-bullous-pemphigoid/</loc>
    <lastmod>2026-03-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-24</news:publication_date>
      <news:title>Japan Approves Dupixent as First Targeted Medicine for Adult Bullous Pemphigoid</news:title>
      <news:keywords>Regulatory Approval, Immunology, Dermatology, Japan</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-23-novartis-presents-new-data-early-symptom-relief-and-long-term-control-complex-skin-diseases-aad-2026/</loc>
    <lastmod>2026-03-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-23</news:publication_date>
      <news:title>Novartis Showcases Immunology Portfolio Data Across 20-Plus Abstracts at AAD 2026</news:title>
      <news:keywords>Reimagine Medicine, Innovation, Clinical Trials, Chronic Illness, Dermatology</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-23-medtronic-omniasecure-defibrillation-lead-first-lead-fda-approval-conduction-system-pacing/</loc>
    <lastmod>2026-03-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-23</news:publication_date>
      <news:title>Medtronic&apos;s OmniaSecure Lead Becomes First Defibrillation Lead Approved by FDA for Conduction System Pacing</news:title>
      <news:keywords>Cardiac Rhythm Management, Medical Devices, FDA Approval, Defibrillation Technology, Conduction System Pacing</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-23-abbott-completes-acquisition-of-exact-sciences/</loc>
    <lastmod>2026-03-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-23</news:publication_date>
      <news:title>Abbott Closes Exact Sciences Deal, Enters $60 Billion Cancer Diagnostics Market</news:title>
      <news:keywords>Acquisition, Cancer Screening, Precision Oncology, Diagnostics, Corporate Strategy</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-20-novartis-agrees-acquire-pan-mutant-selective-pi3ka-inhibitor-strengthening-its-breast-cancer-pipeline/</loc>
    <lastmod>2026-03-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-20</news:publication_date>
      <news:title>Novartis Pays $2 Billion Upfront for Targeted Breast Cancer Drug Candidate SNV4818</news:title>
      <news:keywords>Oncology, Medical Innovations, Cancer, Reimagine Medicine, Acquisition</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-20-abbott-acquisition-of-exact-sciences-set-to-close-on-march-23-2026/</loc>
    <lastmod>2026-03-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-20</news:publication_date>
      <news:title>Abbott&apos;s Acquisition of Exact Sciences Set to Close March 23</news:title>
      <news:keywords>Acquisition, Cancer Screening, Precision Oncology, Diagnostics, Corporate Strategy</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-18-venglustat-breakthrough-therapy-gaucher-disease-type3/</loc>
    <lastmod>2026-03-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-18</news:publication_date>
      <news:title>FDA Grants Breakthrough Therapy Designation to Sanofi&apos;s Venglustat for Type 3 Gaucher Disease</news:title>
      <news:keywords>Regulatory Designation, Rare Disease, Neurology, FDA</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-17-uhg-announces-q1-earnings-release-date/</loc>
    <lastmod>2026-03-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-17</news:publication_date>
      <news:title>UnitedHealth Group to Release First-Quarter 2026 Results on April 21</news:title>
      <news:keywords>Investor Relations, Earnings, Financial Results</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-13-novartis-cosentyx-receives-fda-approval-pediatric-patients-aged-12-moderate-severe-hidradenitis-suppurativa/</loc>
    <lastmod>2026-03-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-13</news:publication_date>
      <news:title>FDA Approves Novartis Cosentyx for Adolescents with Hidradenitis Suppurativa</news:title>
      <news:keywords>Reimagine Medicine, Innovation, Chronic Illness, FDA Approval, Dermatology</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-12-landmark-study-shows-libre-technology-helps-people-with-type-2-diabetes-on-basal-insulin-improve-glucose-management/</loc>
    <lastmod>2026-03-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-12</news:publication_date>
      <news:title>Study Shows Abbott&apos;s FreeStyle Libre Improves Glucose Management for Type 2 Diabetes Patients on Insulin</news:title>
      <news:keywords>Diabetes, Continuous Glucose Monitoring, Clinical Study, FreeStyle Libre, Type 2 Diabetes</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-11-abbott-and-real-madrid-launch-nationwide-effort-to-build-the-next-abbott-dream-team/</loc>
    <lastmod>2026-03-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-11</news:publication_date>
      <news:title>Abbott and Real Madrid Team Up for Youth Soccer and Health Initiative Across the U.S.</news:title>
      <news:keywords>Youth Health, Sports Partnership, Soccer, Nutrition, Community Health</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-11-a-message-to-our-customers-03-2026/</loc>
    <lastmod>2026-03-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-11</news:publication_date>
      <news:title>Stryker Recovers from March Cyberattack, Confirms No Customer Data Compromised</news:title>
      <news:keywords>Cybersecurity, Network Disruption, Customer Updates, Operations</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-10-medtronic-to-acquire-scientia-vascular-marrying-access-and-therapeutic-portfolios-for-neurovascular-care/</loc>
    <lastmod>2026-03-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-10</news:publication_date>
      <news:title>Medtronic to Acquire Scientia Vascular for $550 Million to Bolster Neurovascular Portfolio</news:title>
      <news:keywords>Neurovascular Portfolio, Neuroscience, Medical Device Acquisition, Stroke Treatment, Healthcare Innovation</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-05-board-christel-heydemann-independent-director/</loc>
    <lastmod>2026-03-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-05</news:publication_date>
      <news:title>Sanofi Board Proposes Orange Group CEO Christel Heydemann as Independent Director</news:title>
      <news:keywords>Corporate Governance, Board of Directors, Leadership</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-04-filing-document-enregistrement-universel-annual-financial-report/</loc>
    <lastmod>2026-03-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-04</news:publication_date>
      <news:title>Sanofi Files Amendment to French Annual Financial Report</news:title>
      <news:keywords>Financial Reporting, Regulatory Filing, Investor Relations</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-03-stryker-showcases-continued-innovation-across-orthopaedics-at-aaos-2026-annual-meeting/</loc>
    <lastmod>2026-03-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-03</news:publication_date>
      <news:title>Stryker Unveils 3D-Printed Knee Component and Robotic Surgery Advances at AAOS 2026</news:title>
      <news:keywords>Orthopaedics, Innovation, Surgical Robotics, Medical Devices, Knee Replacement</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-02-stryker-honored-with-hircs-first-ever-enterprise-gold-resiliency-badge/</loc>
    <lastmod>2026-03-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-02</news:publication_date>
      <news:title>Stryker Earns First-Ever Enterprise Gold Resiliency Badge for Supply Chain Excellence</news:title>
      <news:keywords>Awards, Supply Chain, Operational Excellence, Healthcare</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-03-02-rilzabrutinib-orphan-drug-japan-igg4-related-disease/</loc>
    <lastmod>2026-03-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-03-02</news:publication_date>
      <news:title>Sanofi&apos;s Rilzabrutinib Receives Orphan Drug Designation in Japan for IgG4-Related Disease</news:title>
      <news:keywords>Regulatory Designation, Rare Disease, Immunology, Japan</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-27-dupixent-chmp-positive-opinion-csu-young-children/</loc>
    <lastmod>2026-02-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-27</news:publication_date>
      <news:title>EU Regulators Recommend Dupixent Approval for Young Children with Chronic Spontaneous Urticaria</news:title>
      <news:keywords>Regulatory Recommendation, Immunology, Pediatrics, CHMP</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-27-acoziborole-chmp-positive-opinion-sleeping-sickness/</loc>
    <lastmod>2026-02-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-27</news:publication_date>
      <news:title>Single-Dose Sleeping Sickness Treatment From Sanofi Receives Positive EU Regulatory Opinion</news:title>
      <news:keywords>Regulatory Recommendation, Neglected Tropical Diseases, Public Health, CHMP</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-25-uhg-authorizes-payment-quarterly-dividend/</loc>
    <lastmod>2026-02-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-25</news:publication_date>
      <news:title>UnitedHealth Group Board Authorizes $2.21 Per Share Quarterly Dividend</news:title>
      <news:keywords>Investor Relations, Dividend, Financial</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-24-dupixent-approved-us-allergic-fungal-rhinosinusitis/</loc>
    <lastmod>2026-02-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-24</news:publication_date>
      <news:title>FDA Approves Dupixent as First and Only Treatment for Allergic Fungal Rhinosinusitis</news:title>
      <news:keywords>Regulatory Approval, Immunology, Respiratory, FDA</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-17-filing-2025-form-20f-annual-financial-report/</loc>
    <lastmod>2026-02-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-17</news:publication_date>
      <news:title>Sanofi Files 2025 Annual Financial Report with U.S. and French Regulators</news:title>
      <news:keywords>Financial Reporting, Regulatory Filing, Investor Relations, SEC</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-17-duvakitug-phase2b-maintenance-ulcerative-colitis-crohns/</loc>
    <lastmod>2026-02-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-17</news:publication_date>
      <news:title>Sanofi and Teva Report Durable Efficacy for Duvakitug in Inflammatory Bowel Disease Maintenance Study</news:title>
      <news:keywords>Clinical Trial Results, Immunology, Gastroenterology, Phase 2</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-16-beyfortus-lancet-rsv-second-season-benefit/</loc>
    <lastmod>2026-02-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-16</news:publication_date>
      <news:title>Lancet Study Shows Sanofi&apos;s Beyfortus Provides RSV Protection Beyond First Season for Infants</news:title>
      <news:keywords>Vaccines, Pediatrics, RSV, Clinical Evidence, Publication</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-12-belen-garijo-appointed-chief-executive-officer/</loc>
    <lastmod>2026-02-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-12</news:publication_date>
      <news:title>Sanofi Appoints Former Merck KGaA CEO Belen Garijo as New Chief Executive</news:title>
      <news:keywords>Corporate Governance, Leadership, CEO Appointment</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-10-sanofi-completes-acquisition-dynavax/</loc>
    <lastmod>2026-02-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-10</news:publication_date>
      <news:title>Sanofi Completes Acquisition of Dynavax, Expanding Adult Vaccine Portfolio</news:title>
      <news:keywords>Acquisition, Vaccines, Corporate Development</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-02-09-rilzabrutinib-breakthrough-therapy-warm-autoimmune-hemolytic-anemia/</loc>
    <lastmod>2026-02-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-02-09</news:publication_date>
      <news:title>Sanofi&apos;s Rilzabrutinib Earns FDA Breakthrough Therapy Designation for Rare Blood Disorder</news:title>
      <news:keywords>Regulatory Designation, Rare Disease, Hematology, FDA, Japan</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-01-27-uhg-reports-2025-results-and-issues-2026-outlook/</loc>
    <lastmod>2026-01-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-01-27</news:publication_date>
      <news:title>UnitedHealth Group Reports $447.6 Billion in 2025 Revenue, Issues 2026 Guidance</news:title>
      <news:keywords>Investor Relations, Earnings, Financial Results, Annual Results</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-01-22-uhg-provides-testimony-for-house-energy-commerce-ways-means-committee-hearings/</loc>
    <lastmod>2026-01-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-01-22</news:publication_date>
      <news:title>UnitedHealth Group CEO Testifies Before Congress on Healthcare Affordability</news:title>
      <news:keywords>Policy, Healthcare Affordability, Government Affairs, Access</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-01-14-accelerated-medicare-advantage-payments/</loc>
    <lastmod>2026-01-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-01-14</news:publication_date>
      <news:title>UnitedHealthcare Launches Pilot to Accelerate Medicare Advantage Payments to Rural Hospitals</news:title>
      <news:keywords>Medicare Advantage, Rural Health, Health Benefits, Affordability, Provider Relations</news:keywords>
    </news:news>
  </url>
  
  <url>
    <loc>https://healthcarenews.work/news/2026-01-12-new-independent-studies-medicare-advantage-delivers-greater-value-to-federal-government-and-beneficiaries/</loc>
    <lastmod>2026-01-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
    <news:news>
      <news:publication><news:name>Healthcare News Context</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-01-12</news:publication_date>
      <news:title>Independent Studies Find Medicare Advantage Costs Government 9% Less Than Traditional Medicare</news:title>
      <news:keywords>Medicare Advantage, Health Benefits, Research, Policy</news:keywords>
    </news:news>
  </url>
  
</urlset>
